These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15944201

  • 1. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.
    Jarecki J, Chen X, Bernardino A, Coovert DD, Whitney M, Burghes A, Stack J, Pollok BA.
    Hum Mol Genet; 2005 Jul 15; 14(14):2003-18. PubMed ID: 15944201
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J, Butchbach ME, Palomo M, Pease B, Rao M, Bedell L, Keyvan M, Pai G, Mishra R, Haraldsson M, Andresson T, Bragason G, Thosteinsdottir M, Bjornsson JM, Coovert DD, Burghes AH, Gurney ME, Singh J.
    J Med Chem; 2008 Feb 14; 51(3):449-69. PubMed ID: 18205293
    [Abstract] [Full Text] [Related]

  • 3. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
    Vezain M, Saugier-Veber P, Melki J, Toutain A, Bieth E, Husson M, Pedespan JM, Viollet L, Pénisson-Besnier I, Fehrenbach S, Bou J, Frébourg T, Tosi M.
    Eur J Hum Genet; 2007 Oct 14; 15(10):1054-62. PubMed ID: 17609673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
    DiMatteo D, Callahan S, Kmiec EB.
    Exp Cell Res; 2008 Feb 15; 314(4):878-86. PubMed ID: 18078930
    [Abstract] [Full Text] [Related]

  • 7. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
    Baughan T, Shababi M, Coady TH, Dickson AM, Tullis GE, Lorson CL.
    Mol Ther; 2006 Jul 15; 14(1):54-62. PubMed ID: 16580882
    [Abstract] [Full Text] [Related]

  • 8. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
    Boda B, Mas C, Giudicelli C, Nepote V, Guimiot F, Levacher B, Zvara A, Santha M, LeGall I, Simonneau M.
    Eur J Hum Genet; 2004 Sep 15; 12(9):729-37. PubMed ID: 15162126
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
    Angelozzi C, Borgo F, Tiziano FD, Martella A, Neri G, Brahe C.
    J Med Genet; 2008 Jan 15; 45(1):29-31. PubMed ID: 17932121
    [Abstract] [Full Text] [Related]

  • 11. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, Scheffer H, Wokke JH, Van den Berg LH.
    Neurology; 2005 Sep 27; 65(6):820-5. PubMed ID: 16093455
    [Abstract] [Full Text] [Related]

  • 12. Valproic acid increases SMN levels in spinal muscular atrophy patient cells.
    Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, Schussler K, Chen X, Jarecki J, Burghes AH, Taylor JP, Fischbeck KH.
    Ann Neurol; 2003 Nov 27; 54(5):647-54. PubMed ID: 14595654
    [Abstract] [Full Text] [Related]

  • 13. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
    Brichta L, Hofmann Y, Hahnen E, Siebzehnrubl FA, Raschke H, Blumcke I, Eyupoglu IY, Wirth B.
    Hum Mol Genet; 2003 Oct 01; 12(19):2481-9. PubMed ID: 12915451
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Determination of SMN1 and SMN2 copy number using TaqMan technology.
    Anhuf D, Eggermann T, Rudnik-Schöneborn S, Zerres K.
    Hum Mutat; 2003 Jul 01; 22(1):74-8. PubMed ID: 12815596
    [Abstract] [Full Text] [Related]

  • 19. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
    El-Khodor BF, Edgar N, Chen A, Winberg ML, Joyce C, Brunner D, Suárez-Fariñas M, Heyes MP.
    Exp Neurol; 2008 Jul 01; 212(1):29-43. PubMed ID: 18455159
    [Abstract] [Full Text] [Related]

  • 20. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
    Majumdar R, Rehana Z, Al Jumah M, Fetaini N.
    Ann Hum Genet; 2005 Mar 01; 69(Pt 2):216-21. PubMed ID: 15720302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.